TY - JOUR
T1 - Remodelling of primary human CD4+ T cell plasma membrane order by n-3 PUFA
AU - Fan, Yang Yi
AU - Fuentes, Natividad R.
AU - Hou, Tim Y.
AU - Barhoumi, Rola
AU - Li, Xian C.
AU - Deutz, Nicolaas E.P.
AU - Engelen, Marielle P.K.J.
AU - McMurray, David N.
AU - Chapkin, Robert S.
N1 - Publisher Copyright:
Copyright © The Authors 2017.
PY - 2018/1/28
Y1 - 2018/1/28
N2 - Cell membrane fatty acids influence fundamental properties of the plasma membrane, including membrane fluidity, protein functionality, and lipid raft signalling. Evidence suggests that dietary n-3 PUFA may target the plasma membrane of immune cells by altering plasma membrane lipid dynamics, thereby regulating the attenuation of immune cell activation and suppression of inflammation. As lipid-based immunotherapy might be a promising new clinical strategy for the treatment of inflammatory disorders, we conducted in vitro and in vivo experiments to examine the effects of n-3 PUFA on CD4+ T cell membrane order, mitochondrial bioenergetics and lymphoproliferation. n-3 PUFA were incorporated into human primary CD4+ T cells phospholipids in vitro in a dose-dependent manner, resulting in a reduction in whole cell membrane order, oxidative phosphorylation and proliferation. At higher doses, n-3 PUFA induced unique phase separation in T cell-derived giant plasma membrane vesicles. Similarly, in a short-term human pilot study, supplementation of fish oil (4 g n-3 PUFA/d) for 6 weeks in healthy subjects significantly elevated EPA (20 : 5n-3) levels in CD4+ T cell membrane phospholipids, and reduced membrane lipid order. These results demonstrate that the dynamic reshaping of human CD4+ T cell plasma membrane organisation by n-3 PUFA may modulate down-stream clonal expansion.
AB - Cell membrane fatty acids influence fundamental properties of the plasma membrane, including membrane fluidity, protein functionality, and lipid raft signalling. Evidence suggests that dietary n-3 PUFA may target the plasma membrane of immune cells by altering plasma membrane lipid dynamics, thereby regulating the attenuation of immune cell activation and suppression of inflammation. As lipid-based immunotherapy might be a promising new clinical strategy for the treatment of inflammatory disorders, we conducted in vitro and in vivo experiments to examine the effects of n-3 PUFA on CD4+ T cell membrane order, mitochondrial bioenergetics and lymphoproliferation. n-3 PUFA were incorporated into human primary CD4+ T cells phospholipids in vitro in a dose-dependent manner, resulting in a reduction in whole cell membrane order, oxidative phosphorylation and proliferation. At higher doses, n-3 PUFA induced unique phase separation in T cell-derived giant plasma membrane vesicles. Similarly, in a short-term human pilot study, supplementation of fish oil (4 g n-3 PUFA/d) for 6 weeks in healthy subjects significantly elevated EPA (20 : 5n-3) levels in CD4+ T cell membrane phospholipids, and reduced membrane lipid order. These results demonstrate that the dynamic reshaping of human CD4+ T cell plasma membrane organisation by n-3 PUFA may modulate down-stream clonal expansion.
KW - CD4 T cells
KW - Generalised polarisation
KW - Giant plasma membrane vesicles
KW - Phase separation
KW - n-3 PUFA
UR - http://www.scopus.com/inward/record.url?scp=85042231877&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85042231877&partnerID=8YFLogxK
U2 - 10.1017/S0007114517003385
DO - 10.1017/S0007114517003385
M3 - Article
C2 - 29249211
AN - SCOPUS:85042231877
SN - 0007-1145
VL - 119
SP - 163
EP - 175
JO - British Journal of Nutrition
JF - British Journal of Nutrition
IS - 2
ER -